← All FR Documents
Notice

Center for Scientific Review; Notice of Closed Meetings

In Plain English

What is this Federal Register notice?

This is a notice published in the Federal Register by Health and Human Services Department, National Institutes of Health. Notices communicate information, guidance, or policy interpretations but may not create new binding obligations.

Is this rule final?

This document is classified as a notice. It may or may not create enforceable regulatory obligations depending on its specific content.

Who does this apply to?

Consult the full text of this document for specific applicability provisions. The affected parties depend on the regulatory scope defined within.

When does it take effect?

No specific effective date is indicated. Check the full text for date provisions.

Why it matters: This notice communicates agency policy or guidance regarding applicable regulations.

Document Details

Document Number2025-18930
TypeNotice
PublishedSep 30, 2025
Effective Date-
RIN-
Docket ID-
Text FetchedYes

Agencies & CFR References

CFR References:
None

Linked CFR Parts

PartNameAgency
No linked CFR parts

Paired Documents

TypeProposedFinalMethodConf
No paired documents

External Links

📋 Extracted Requirements 0 found

No extractable regulatory requirements found in this document. This is common for documents that:

  • Incorporate requirements by reference (IBR) to external documents
  • Are procedural notices without substantive obligations
  • Contain only preamble/explanation without regulatory text

Full Document Text (701 words · ~4 min read)

Text Preserved
<NOTICE> DEPARTMENT OF HEALTH AND HUMAN SERVICES <SUBAGY>National Institutes of Health</SUBAGY> <SUBJECT>Center for Scientific Review; Notice of Closed Meetings</SUBJECT> Pursuant to section 1009 of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. <EXTRACT> <E T="03">Name of Committee:</E> Center for Scientific Review Special Emphasis Panel PAR Panel: Cancer Biomarker Research (R21). <E T="03">Date:</E> November 14, 2025. <E T="03">Time:</E> 9:00 a.m. to 5:00 p.m. <E T="03">Agenda:</E> To review and evaluate grant applications. <E T="03">Address:</E> National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892. <E T="03">Meeting Format:</E> Virtual Meeting. <E T="03">Contact Person:</E> Robert F. Gahl, BS, Ph.D., Scientific Review Officer, Cancer Diagnosis, Prevention & Therapeutics, Division of Translational and Clinical Sciences, Center for Scientific Review, National Cancer Institute, NIH, Rockville, MD 20850, (240) 276-7869, <E T="03">robert.gahl@nih.gov</E> . <E T="03">Name of Committee:</E> Center for Scientific Review Special Emphasis Panel Research Enhancement Awards: Molecular Genetics, Cellular and Cancer Biology. <E T="03">Date:</E> November 20, 2025. <E T="03">Time:</E> 9:00 a.m. to 6:00 p.m. <E T="03">Agenda:</E> To review and evaluate grant applications. <E T="03">Address:</E> National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892. <E T="03">Meeting Format:</E> Virtual Meeting. <E T="03">Contact Person:</E> Sandip Bhattacharyya, Scientific Review Officer, Scientific Review Program, DEA/NIAID/NIH/DHHS, 5601 Fishers Lane, MSC-9823, Rockville, MD 20852, (301) 594-7121, <E T="03">sandip.bhattacharyya@nih.gov</E> . <E T="03">Name of Committee:</E> Center for Scientific Review Special Emphasis Panel RFA Panel: Special Topics on Clinical Care, and Influences on Health and Disease Management. <E T="03">Date:</E> December 2, 2025. <E T="03">Time:</E> 9:30 a.m. to 6:00 p.m. <E T="03">Agenda:</E> To review and evaluate grant applications. <E T="03">Address:</E> National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892. <E T="03">Meeting Format:</E> Virtual Meeting. <E T="03">Contact Person:</E> Marisa Srivareerat, Ph.D., Scientific Review Officer, Scientific Review Branch, Office of Extramural Policy, National Institute on Drug Abuse, NIH, 11601 Landsdown Street, 3WF Room 09C49, Bethesda, MD 20892, (301) 435-1258, <E T="03">marisa.srivareerat@nih.gov</E> . <E T="03">Name of Committee:</E> Center for Scientific Review Special Emphasis Panel Small Business: Computational, Modeling, and Biodata Management. <E T="03">Date:</E> December 3-4, 2025. <E T="03">Time:</E> 9:30 a.m. to 6:00 p.m. <E T="03">Agenda:</E> To review and evaluate grant applications. <E T="03">Address:</E> National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892. <E T="03">Meeting Format:</E> Virtual Meeting. <E T="03">Contact Person:</E> Joonil Seog, SCD, Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892, 301-402-9791, <E T="03">joonil.seog@nih.gov</E> . <E T="03">Name of Committee:</E> Center for Scientific Review Special Emphasis Panel PAR Panel: Neurotherapeutic Agent Identification with Innovation Grants to Nurture Initial Translational Efforts (IGNITE). <E T="03">Date:</E> December 3, 2025. <E T="03">Time:</E> 10:00 a.m. to 6:00 p.m. <E T="03">Agenda:</E> To review and evaluate grant applications. <E T="03">Address:</E> National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892. <E T="03">Meeting Format:</E> Virtual Meeting. <E T="03">Contact Person:</E> Jessica Bellinger, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 3158, Bethesda, MD 20892, (301) 827-4446, <E T="03">bellingerjd@csr.nih.gov</E> . <E T="03">Name of Committee:</E> Center for Scientific Review Special Emphasis Panel Member Conflict: Topics in Adaptive and Innate Immunity. <E T="03">Date:</E> December 9, 2025. <E T="03">Time:</E> 10:00 a.m. to 6:00 p.m. <E T="03">Agenda:</E> To review and evaluate grant applications. <E T="03">Address:</E> National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892. <E T="03">Meeting Format:</E> Virtual Meeting. <E T="03">Contact Person:</E> Seyhan Boyoglu barnum, Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892, (301) 480-1446, <E T="03">seyhan.boyoglu-barnum@nih.gov</E> . <FP>(Catalogue of Federal Domestic Assistance Program Nos. 93.306, Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333, 93.337, 93.393-93.396, 93.837-93.844, 93.846-93.878, 93.892, 93.893, National Institutes of Health, HHS)</FP> </EXTRACT> <SIG> <DATED> Dated: September 25, 2025.</DATED> <NAME>Bruce A. George, </NAME> Program Analyst, Office of Federal Advisory Committee Policy. </SIG> <FRDOC>[FR Doc. 2025-18930 Filed 9-29-25; 8:45 am]</FRDOC> </NOTICE>
This text is preserved for citation and comparison. View the official version for the authoritative text.